BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 18191066)

  • 41. [Rapid-acting insulin analogues].
    Matsuda A; Kuzuya T
    Nihon Rinsho; 1999 Mar; 57(3):709-18. PubMed ID: 10199158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence-based insulin treatment in type 1 diabetes mellitus.
    Jacobsen IB; Henriksen JE; Hother-Nielsen O; Vach W; Beck-Nielsen H
    Diabetes Res Clin Pract; 2009 Oct; 86(1):1-10. PubMed ID: 19647887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
    Bruttomesso D; Costa S; Baritussio A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.
    Kapellen TM; Klinkert C; Heidtmann B; Jakisch B; Haberland H; Hofer SE; Holl RW
    Postgrad Med; 2010 May; 122(3):98-105. PubMed ID: 20463419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of insulin pumps improves the metabolic control in children and adolescents with type 1 diabetes.
    Toni S; Reali MF; Fasulo A; Festini P; Medici A; Martinucci ME
    Arch Dis Child; 2004 Aug; 89(8):796-7. PubMed ID: 15269092
    [No Abstract]   [Full Text] [Related]  

  • 46. Is insulin pump therapy better than injection for adolescents with diabetes?
    Wu YP; Graves MM; Roberts MC; Mitchell AC
    Diabetes Res Clin Pract; 2010 Aug; 89(2):121-5. PubMed ID: 20488572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin analogues: an example of applied medical science.
    Sheldon B; Russell-Jones D; Wright J
    Diabetes Obes Metab; 2009 Jan; 11(1):5-19. PubMed ID: 19120431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
    DeWitt DE; Hirsch IB
    JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30, 50, 70 and pure insulin aspart: a randomized, quadruple crossover study.
    Thorisdottir RL; Parkner T; Chen JW; Ejskjaer N; Christiansen JS
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):216-21. PubMed ID: 19175369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Innovative insulins--where do analogues fit?
    Phillips LK; Phillips PJ
    Aust Fam Physician; 2006 Dec; 35(12):969-73. PubMed ID: 17149471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
    Meneghini L
    Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R; de Beaufort C; Hoey H; Anderson B
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.
    Tamborlane WV; Sikes KA; Steffen AT; Weinzimer SA
    Diabetes Res Clin Pract; 2006 Dec; 74 Suppl 2():S112-5. PubMed ID: 17182301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin therapy in children and adolescents with Type 1 diabetes.
    McAssey K; Perlman K; Daneman D
    Diabetes Nutr Metab; 1999 Apr; 12(2):86-95. PubMed ID: 10554891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [New trends in therapy of diabetes. More freedom, fewer risks, comfortable insulin administration].
    Harsch IA; Hahn EG; Ficker JH
    MMW Fortschr Med; 2000 Jul; 142(28-29):24-6. PubMed ID: 10959155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus.
    Fiallo-Scharer R; Horner B; McFann K; Walravens P; Chase HP
    J Pediatr; 2006 Apr; 148(4):481-4. PubMed ID: 16647408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
    Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
    Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Type 1 diabetes in children and adolescents--new strategies in management and treatment].
    Kordonouri O; von Schütz W; Meyer N; Aschemeier B; Kracht T; Danne T
    Med Monatsschr Pharm; 2008 Jun; 31(6):200-6; quiz 207-8. PubMed ID: 18661909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.